共 50 条
- [2] Cost-Effectiveness of Pembrolizumab for the treatment of Non-Small-Cell lung cancer: A systematic review [J]. FRONTIERS IN ONCOLOGY, 2022, 12
- [7] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC) [J]. BMC PULMONARY MEDICINE, 2014, 14
- [8] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC) [J]. BMC Pulmonary Medicine, 14
- [9] PROGNOSTIC FACTORS IN STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1104 - 1111